Shelly Plapp

Shelly Plapp is an accomplished regulatory affairs professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as the Senior Director of Regulatory Affairs Operations at Adverum Biotechnologies, Inc. since February 2022, Shelly has previously held senior leadership roles at Treximo, West Therapeutic Development, and Melinta Therapeutics, where responsibilities included managing teams to ensure the accuracy and quality of regulatory submissions. Shelly's career began as a Regulatory Affairs Associate at TAP Pharmaceuticals, progressing through various regulatory roles at Abbott and Lundbeck, where notable contributions included the development of workload metrics and the establishment of operational policies to enhance productivity and efficiency.